US Stock MarketDetailed Quotes

RANI Rani Therapeutics

Watchlist
  • 3.140
  • +0.110+3.63%
Trading Mar 28 10:23 ET
81.77MMarket Cap-2360P/E (TTM)

Rani Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
4.17%66.1M
-23.16%13.43M
9.26%17.86M
15.44%18.29M
19.85%16.52M
16.82%63.45M
30.83%17.48M
-41.18%16.34M
119.52%15.85M
131.44%13.78M
Selling and administrative expenses
-1.37%26.48M
-17.87%5.83M
-8.34%6.64M
14.07%7.21M
9.94%6.8M
-3.56%26.84M
19.36%7.1M
-54.25%7.24M
82.63%6.32M
137.40%6.19M
-General and administrative expense
-1.37%26.48M
-17.87%5.83M
-8.34%6.64M
14.07%7.21M
9.94%6.8M
-3.56%26.84M
19.36%7.1M
-54.25%7.24M
82.63%6.32M
137.40%6.19M
Research and development costs
8.24%39.62M
-26.77%7.61M
23.26%11.22M
16.35%11.09M
27.94%9.71M
38.23%36.61M
40.03%10.39M
-23.88%9.1M
153.47%9.53M
126.80%7.59M
Operating profit
-4.17%-66.1M
23.16%-13.43M
-9.26%-17.86M
-15.44%-18.29M
-19.85%-16.52M
-22.97%-63.45M
-30.83%-17.48M
41.18%-16.34M
-201.39%-15.85M
-165.10%-13.78M
Net non-operating interest income expense
-1,107.91%-1.78M
-727.27%-621K
-1,866.67%-477K
-1,157.14%-370K
-2,206.67%-316K
146.95%177K
482.35%99K
127.84%27K
122.44%35K
110.64%15K
Non-operating interest income
164.50%3.3M
-17.48%675K
121.37%839K
2,460.00%896K
5,840.00%891K
1,302.25%1.25M
5,012.50%818K
2,815.38%379K
169.23%35K
-68.09%15K
Non-operating interest expense
374.79%5.09M
80.25%1.3M
273.86%1.32M
--1.27M
--1.21M
129.83%1.07M
72,000.00%719K
220.00%352K
--0
--0
Other net income (expense)
Income before tax
-7.28%-67.88M
19.15%-14.06M
-12.36%-18.33M
-18.04%-18.66M
-22.28%-16.83M
-19.28%-63.27M
-30.26%-17.38M
43.08%-16.32M
-188.33%-15.81M
-147.79%-13.77M
Income tax
0
0
0
0
0
70.73%70K
-2.50%-41K
-389.19%-107K
15,300.00%154K
46.51%63K
Net income
-7.17%-67.88M
18.95%-14.06M
-13.10%-18.33M
-16.90%-18.66M
-21.72%-16.83M
-19.32%-63.34M
-30.34%-17.34M
43.53%-16.21M
-191.08%-15.97M
-147.02%-13.83M
Net income continuous Operations
-7.17%-67.88M
18.95%-14.06M
-13.10%-18.33M
-16.90%-18.66M
-21.72%-16.83M
-19.32%-63.34M
-30.34%-17.34M
43.53%-16.21M
-191.08%-15.97M
-147.02%-13.83M
Minority interest income
-3.53%-33.91M
18.69%-6.96M
-10.69%-9.14M
-12.22%-9.36M
-11.24%-8.46M
26.81%-32.76M
-5.42%-8.56M
67.71%-8.25M
-52.09%-8.34M
-35.85%-7.61M
Net income attributable to the parent company
-11.06%-33.97M
19.21%-7.1M
-15.61%-9.2M
-22.02%-9.3M
-34.53%-8.37M
-267.16%-30.59M
-69.32%-8.79M
-153.18%-7.96M
-7.62M
-6.22M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-11.06%-33.97M
19.21%-7.1M
-15.61%-9.2M
-22.02%-9.3M
-34.53%-8.37M
-267.16%-30.59M
-69.32%-8.79M
-153.18%-7.96M
-7.62M
-6.22M
Basic earnings per share
-3.91%-1.33
22.86%-0.27
-9.09%-0.36
-19.35%-0.37
-13.79%-0.33
-197.67%-1.28
-29.63%-0.35
-106.25%-0.33
-0.31
-0.29
Diluted earnings per share
-3.91%-1.33
22.86%-0.27
-9.09%-0.36
-19.35%-0.37
-13.79%-0.33
-197.67%-1.28
-29.63%-0.35
-106.25%-0.33
-0.31
-0.29
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 4.17%66.1M-23.16%13.43M9.26%17.86M15.44%18.29M19.85%16.52M16.82%63.45M30.83%17.48M-41.18%16.34M119.52%15.85M131.44%13.78M
Selling and administrative expenses -1.37%26.48M-17.87%5.83M-8.34%6.64M14.07%7.21M9.94%6.8M-3.56%26.84M19.36%7.1M-54.25%7.24M82.63%6.32M137.40%6.19M
-General and administrative expense -1.37%26.48M-17.87%5.83M-8.34%6.64M14.07%7.21M9.94%6.8M-3.56%26.84M19.36%7.1M-54.25%7.24M82.63%6.32M137.40%6.19M
Research and development costs 8.24%39.62M-26.77%7.61M23.26%11.22M16.35%11.09M27.94%9.71M38.23%36.61M40.03%10.39M-23.88%9.1M153.47%9.53M126.80%7.59M
Operating profit -4.17%-66.1M23.16%-13.43M-9.26%-17.86M-15.44%-18.29M-19.85%-16.52M-22.97%-63.45M-30.83%-17.48M41.18%-16.34M-201.39%-15.85M-165.10%-13.78M
Net non-operating interest income expense -1,107.91%-1.78M-727.27%-621K-1,866.67%-477K-1,157.14%-370K-2,206.67%-316K146.95%177K482.35%99K127.84%27K122.44%35K110.64%15K
Non-operating interest income 164.50%3.3M-17.48%675K121.37%839K2,460.00%896K5,840.00%891K1,302.25%1.25M5,012.50%818K2,815.38%379K169.23%35K-68.09%15K
Non-operating interest expense 374.79%5.09M80.25%1.3M273.86%1.32M--1.27M--1.21M129.83%1.07M72,000.00%719K220.00%352K--0--0
Other net income (expense)
Income before tax -7.28%-67.88M19.15%-14.06M-12.36%-18.33M-18.04%-18.66M-22.28%-16.83M-19.28%-63.27M-30.26%-17.38M43.08%-16.32M-188.33%-15.81M-147.79%-13.77M
Income tax 0000070.73%70K-2.50%-41K-389.19%-107K15,300.00%154K46.51%63K
Net income -7.17%-67.88M18.95%-14.06M-13.10%-18.33M-16.90%-18.66M-21.72%-16.83M-19.32%-63.34M-30.34%-17.34M43.53%-16.21M-191.08%-15.97M-147.02%-13.83M
Net income continuous Operations -7.17%-67.88M18.95%-14.06M-13.10%-18.33M-16.90%-18.66M-21.72%-16.83M-19.32%-63.34M-30.34%-17.34M43.53%-16.21M-191.08%-15.97M-147.02%-13.83M
Minority interest income -3.53%-33.91M18.69%-6.96M-10.69%-9.14M-12.22%-9.36M-11.24%-8.46M26.81%-32.76M-5.42%-8.56M67.71%-8.25M-52.09%-8.34M-35.85%-7.61M
Net income attributable to the parent company -11.06%-33.97M19.21%-7.1M-15.61%-9.2M-22.02%-9.3M-34.53%-8.37M-267.16%-30.59M-69.32%-8.79M-153.18%-7.96M-7.62M-6.22M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -11.06%-33.97M19.21%-7.1M-15.61%-9.2M-22.02%-9.3M-34.53%-8.37M-267.16%-30.59M-69.32%-8.79M-153.18%-7.96M-7.62M-6.22M
Basic earnings per share -3.91%-1.3322.86%-0.27-9.09%-0.36-19.35%-0.37-13.79%-0.33-197.67%-1.28-29.63%-0.35-106.25%-0.33-0.31-0.29
Diluted earnings per share -3.91%-1.3322.86%-0.27-9.09%-0.36-19.35%-0.37-13.79%-0.33-197.67%-1.28-29.63%-0.35-106.25%-0.33-0.31-0.29
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg